HDAC3 and cancer: The results showed that HDAC3 silencing reduced the phosphorylation of CDK1 Y15 and STAT3 Y705 followed by reduction of CD44 and Sox2, which resulted in the impairment of cancer cell stemness (Additional file 1: Figure S8a–c).